Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Therma Bright ( (TSE:THRM) ) just unveiled an update.
Therma Bright Inc. has expanded its partnership with Gen-X Med, a Texas-based medical product distributor, to enhance the distribution of its Venowave™ VW5 device, which is designed to improve blood circulation and aid post-operative recovery. This strategic move targets the growing specialized knee surgery market in the U.S., aiming to reduce post-surgical complications and healthcare costs, aligning with the company’s mission to improve patient outcomes. The global compression therapy market is expected to grow significantly, presenting further opportunities for Therma Bright’s innovative solutions.
Spark’s Take on TSE:THRM Stock
According to Spark, TipRanks’ AI Analyst, TSE:THRM is a Neutral.
Therma Bright’s overall score is primarily driven by its challenging financial performance and weak technical indicators. The valuation reflects ongoing losses, while positive corporate events provide some potential upside.
To see Spark’s full report on TSE:THRM stock, click here.
More about Therma Bright
Therma Bright Inc. is a developer and investment partner specializing in advanced diagnostic and medical device technologies. The company focuses on creating innovative solutions that address key healthcare challenges, trading on TSXV, OTCQB, and FSE exchanges.
Average Trading Volume: 66,135
Technical Sentiment Signal: Sell
Current Market Cap: C$6.25M
Find detailed analytics on THRM stock on TipRanks’ Stock Analysis page.